Loneliness is more than a state of mind—it could be a harbinger of more severe health issues, including Parkinson’s disease. This unsettling connection comes to light through a recent study published in JAMA Neurology, which points to a 37% increased likelihood of Parkinson’s diagnosis among those who identify as lonely. The Study and Its Findings… Continue reading Unraveling the Link Between Loneliness and Parkinson’s Disease
Author: Parkie
Title: Cognitive Decline in Parkinson’s: Early Detection and Management
Parkinson’s disease (PD) is not just a movement disorder; cognitive impairment is also a significant feature. Cognitive issues, ranging from mild cognitive impairment (MCI) to full-blown dementia, can affect people with PD even early in their diagnosis. This blog post will delve into the complexities of cognitive impairment in Parkinson’s, discussing its types, prevalence, risk… Continue reading Title: Cognitive Decline in Parkinson’s: Early Detection and Management
Mucuna Pruriens: A Natural PD Therapy
Exploring the therapeutic potential of Mucuna pruriens (MP) in treating Parkinson’s disease (PD) offers an intriguing alternative to synthetic medications. This blog post delves into the pharmacological benefits of MP, focusing on its naturally occurring L-DOPA content, the dosing protocols for its use, and its incorporation into mainstream PD treatment paradigms. Natural L-DOPA Source in… Continue reading Mucuna Pruriens: A Natural PD Therapy
GLP-1’s Impact on Parkinson’s Disease
The potential of GLP-1 (Glucagon-Like Peptide-1) agonists in treating neurodegenerative conditions like Parkinson’s disease is gaining significant scientific interest, particularly for their dual capacity to modulate both metabolic functions and neurological pathways. In this comprehensive discussion, we delve deep into how GLP-1 agonists not only preserve motor functions but also bolster cognitive faculties, offering new… Continue reading GLP-1’s Impact on Parkinson’s Disease
Gut-Brain Link in Parkinson’s
Parkinson’s disease (PD), a neurodegenerative condition traditionally characterized by motor symptoms such as tremors and rigidity, has complex origins that might involve more than just the brain. Recent research delves into how elements such as alpha-synuclein, a protein found both in the brain and the gut, could play a crucial role in the disease’s progression… Continue reading Gut-Brain Link in Parkinson’s